Some people get Alzheimer’s pathology. No symptoms. They’re fine.
Why?
It’s a massive mystery in neuroscience right now. Evgenia Salta put it plainly: about 30 percent of older adults develop the physical hallmarks of Alzheimer’s disease in their brains yet never experience dementia. “We really don’t know,” she said. “That’s a big mystery.”
Researchers are obsessed with this gap between the damage seen on scans and the mind staying sharp. It’s called cognitive resilience. And now, looking closely at the wiring, we have a clue.
It’s Not Just About Numbers
The theory? Resilient brains repair themselves better.
“Perhaps they can add new brain cells,” Salta suggests. To this degenerating network.
This taps into a decades-old debate: does adult neurogenesis —the birth of new neurons in an aging brain—actually happen in humans? Animal models say yes. Human evidence? Messy. Controversial.
Salta’s team decided to check for themselves. They went to the Netherlands Brain Bank and pulled up donated tissue. Three groups: healthy controls, Alzheimer’s patients, and those resilient individuals with pathology but no symptoms. They targeted a tiny slice of the hippocampus. Memory central.
Finding these cells was hell.
“These cells are extremely rare,” Salta admits. “We really had to zoom in.”
They didn’t rely on assumptions from mouse brains either. New methods. Better precision.
The result? Immature neurons were everywhere. In everyone.
Even in brains averaging 80-plus years of old, the team found young, developing neural cells in all groups. Shocking, maybe, but consistent.
Quality Over Quantity
Here is the twist.
The resilient people didn’t have more immature neurons than the Alzheimer’s patients. Initial hypotheses died here.
The difference wasn’t the count. It was the function.
In brains that stayed sharp despite disease, those immature cells flipped a switch. “They seem to activate programs that help them survive and cope,” Salta says. Lower inflammation signals. Fewer death cues.
It’s not a replacement crew.
It’s a support system. “It might not just be about replacing lost neurons,” she notes. The cells might support surrounding tissue. Keeping things youthful. Alive. “A sort of fertilizer,” she likens it. “For a garden starting to fall apart.”
Can you imagine tending a crumbling garden? Just enough fertilizer to keep the flowers blooming. That might be what’s happening.
But caution. Salta doesn’t want headlines getting too ahead. The study observes correlations, not direct causality. They assume the function based on data signatures, but can’t watch the process in real time.
“This is one piece,” she reminds us. “Never just one factor.”
The Future is Unstable
So what changes?
The focus of Alzheimer’s research is shifting. Away from just how the disease attacks, and toward how it gets resisted. Salta sees a trajectory. A decision point in the aging process where some stay stable, and others dive into decline.
“We want to understand what drives that.”
Future studies will watch these immature neurons. Watch how they interact with neighbors. Do the talks happen? Do they send help?
The implication is wild if true. The brain, old and fragile, isn’t just a passive victim. It’s adapting. Fighting. Maybe growing its own fertilizer.
“Cognitive resilience is extremely excited,” Salta said—wait, typo. “Extremely exciting.”
If we find what protects those specific brains? Therapeutic strategies follow. Maybe drugs that mimic this resilience.
Maybe it’s already happening inside your head right now. We just have no way of checking. Yet.
